Magnetic drug delivery systems

作     者：刘洋 李明熹 杨芳 顾宁 Yang Liu;Mingxi Li;Fang Yang;Ning Gu

作者机构：State Key Laboratory of Bioelectronics Jiangsu Key Laboratory for Biomaterials and Devices School of Biological Science and Medical EngineeringSoutheast University Nanjing 210096 China 

基　　金：financially funded by the National Natural Science Foundation of China (NSFC, 31370019, 61420106012) the project of National Key Basic Research Program of China (2013CB733804) The funding partially comes from the Fundamental Research Funds for the Central Universities (2242016K41072) Zhong Ying Young Scholar of Southeast University as well as the support fromthe Collaborative Innovation Center of Suzhou Nano Science and Technology 

出 版 物：《Science China Materials》 (中国科学（材料科学（英文版）)

年 卷 期：2017年第60卷第6期

页      码：471-486页

摘      要：There has been unprecedented progress in the development of biomedical nanotechnology and nanoma- terials over the past few decades, and nanoparticle-based drug delivery systems （DDSs） have great potential for clin- ical applications. Among these, magnetic drug delivery systems （MDDSs） based on magnetic nanoparticles （MNPs） are attracting increasing attention owing to their favor- able biocompatibility and excellent multifunctional loading capability. MDDSs primarily have a solid core of super paramagnetic maghemite （y-Fe^03） or magnetite （Fe304） nanoparticles ranging in size from 10 to 100nm. Their surface can be functionalized by organic and/or inorganic modification. Further conjugation with targeting ligands, drug loading, and MNP assembly can provide complex magnetic delivery systems with improved targeting efficacy and reduced toxicity. Owing to their sensitive response to external magnetic fields, MNPs and their assemblies have been developed as novel smart delivery systems. In this review, we first summarize the basic physicochemical and magnetic properties of desirable MDDSs that fulfill the requirements for specific clinical applications. Secondly, we discuss the surface modifications and functionalization issues that arise when designing elaborate MDDSs for future clinical uses. Finally, we highlight recent progress in the design and fabrication of MNPs, magnetic assemblies, and magnetic microbnbbles and liposomes as MDDSs for cancer diagnosis and therapy. Recently, researchers have focused on enhanced targeting efficacy and theranostics by applying step-by-step sequential treatment, and by magnetically mod- ulating dosing regimens, which are the current challenges for clinical applications.

主 题 词：magnetic nanoparticles magnetic assembly drugdelivery system multimodality theranostics 

学科分类：1007[医学-药学类] 10[医学] 

核心收录：

D　O　I：10.1007/s40843.017-9049-0

馆 藏 号：203233231...